Medicine and Dentistry
Lung
82%
Lung Transplantation
75%
Lung Cancer
72%
Non Small Cell Lung Cancer
61%
Pneumonectomy
56%
Neoplasm
54%
Diseases
46%
Malignant Neoplasm
45%
Surgeon
43%
Lobectomy
37%
Thorax Surgery
35%
Left Ventricular Assist Device
30%
Recurrent Disease
29%
Overall Survival
28%
Emphysema
26%
Esophagectomy
24%
Esophageal Cancer
22%
COVID-19
21%
Infection
20%
Radiation Therapy
19%
Extracorporeal Membrane Oxygenation
19%
Allograft
19%
Video-Assisted Thoracoscopic Surgery
18%
Computer Assisted Tomography
18%
Odds Ratio
17%
Thoracotomy
17%
Operating Room
15%
Congestive Heart Failure
15%
Chronic Obstructive Pulmonary Disease
15%
Metastatic Carcinoma
15%
Cancer
15%
Bronchoscopy
13%
Hypercapnia
13%
Primary Graft Dysfunction
13%
Acute Respiratory Distress Syndrome
13%
Survival Rate
13%
Fistula
13%
General Surgery
13%
Carbon Dioxide
12%
Adenosine Triphosphatase (Potassium Sodium)
12%
Postoperative Complication
11%
Breast Cancer
10%
Biopsy Technique
10%
Pleura Mesothelioma
10%
Health Care Cost
10%
Dyspnea
10%
Long Term Survival
10%
Epithelial Cell
10%
Lymph Node
10%
Adjuvant Therapy
10%
Surgical Approach
9%
Chemoradiotherapy
9%
Immune Response
9%
Logistic Regression Analysis
9%
Thoracoscopy
9%
Segmentectomy
9%
Macrophage
9%
Lung Nodule
9%
Surgical Technique
9%
Hazard Ratio
9%
Tracheobronchomalacia
9%
Ventricular Assist Device
8%
Systematic Review
8%
Forced Expiratory Volume
8%
Biological Marker
8%
Bronchiolitis Obliterans
8%
Immunotherapy
8%
Esophagus Carcinoma
8%
Vein Graft
8%
Cardiothoracics
7%
Neoadjuvant Therapy
7%
Quality Improvement
7%
Quality of Life
7%
Clinical Stage
7%
Surgical Mortality
7%
Circulating Tumor Cell
7%
Diabetes
7%
Adenocarcinoma
7%
Pancreas Cancer
7%
Esophagus
7%
Artificial Respiration
6%
Cancer Surgery
6%
Virus
6%
Mortality Rate
6%
Hydrolase
6%
Proportional Hazards Model
6%
down Regulation
6%
Pancreaticoduodenectomy
6%
Fibrosis
6%
Combination Therapy
6%
Atrial Fibrillation
6%
Cisplatin
6%
Alveolar Macrophage
6%
Comorbidity
6%
Silo-Filler's Disease
6%
Adjuvant Chemotherapy
6%
Surgical Anastomosis
6%
Interstitial Cystitis
6%
Minimally Invasive Procedure
6%
Acute Myeloid Leukemia
6%
Keyphrases
Lung Transplantation
100%
Lung
58%
Non-small Cell Lung Cancer (NSCLC)
57%
Lung Cancer
43%
K-ATPase
39%
Resection
35%
Tumor
29%
Lung Volume Reduction Surgery
26%
Overall Survival
26%
COVID-19
24%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
22%
Confidence Interval
21%
Thoracic Surgery
20%
Esophageal Cancer
20%
Hypercapnia
20%
Chemotherapy
20%
Alveolar Epithelial Cells
19%
Primary Graft Dysfunction
19%
Surgeons
19%
Odds Ratio
18%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
18%
Lobectomy
18%
Video-assisted Thoracoscopic Surgery
18%
Emphysema
17%
Left Ventricular Assist Device Implantation
16%
Risk Factors
15%
Transplantation
15%
Bronchiolitis Obliterans Syndrome
15%
Postoperative Mortality
15%
Acute Respiratory Distress Syndrome
15%
Esophagectomy
14%
Resectable Lung Cancer
14%
Patient Selection
14%
RNA Sequencing (RNA-seq)
13%
Forced Expiratory Volume in 1 Second (FEV1)
13%
Computed Tomography
13%
Society of Thoracic Surgeons
13%
Operating Room
13%
Pneumonia
12%
Human Tissue
11%
United States
11%
Human Lung
11%
Immune Response
11%
Long-term Survival
11%
Self-antigens
11%
Induction Therapy
11%
Thoracoscopic
11%
Diabetes
11%
Operative
10%
Acute Rejection
10%
Macrophages
10%
Surgical Outcomes
10%
Surgical Approach
10%
Plasma Membrane
10%
Malignant Pleural Mesothelioma
10%
Gene Expression
10%
Surgical Resection
10%
Combined Modality Therapy
9%
Adjuvant Therapy
9%
Stage I Lung Cancer
9%
National Cancer Database
9%
Lung Allograft
9%
Acute Myeloid Leukemia
9%
Radiotherapy
9%
Non-small Cell Lung Cancer Patients
9%
Postoperative Complications
9%
T Cells
9%
HeartMate II
9%
Regulatory T Cells
9%
Cardiothoracic Surgery
9%
Hazard Ratio
9%
Vein Graft
9%
Edema
9%
Influenza Virus
9%
Chronic Obstructive Pulmonary Disease
9%
Collagen V
9%
Local Recurrence
9%
Mechanical Ventilation
8%
Dopamine
8%
High Risk
8%
Non-classical Monocytes
8%
Survival Rate
8%
Donor Lung
8%
Left Ventricular Assist Device
8%
Multivariable
8%
Transcriptome
8%
Quality Measures
8%
Monocytes
8%
Post-esophagectomy
8%
Pulmonary Lobectomy
8%
RNA-seq Data
8%
Lung Allograft Rejection
8%
Thoracoscopy
8%
Malignancy
8%
Bronchoscopy
8%
Tracheobronchomalacia
8%
Exosomes
8%
Alveolar Macrophages
8%
NCCN Guidelines
8%
Dyspnea
8%